Albumin is the major carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in human plasma.
Albumin
Human plasma
perfluoroalkyl substances (PFAS)
Journal
Environment international
ISSN: 1873-6750
Titre abrégé: Environ Int
Pays: Netherlands
ID NLM: 7807270
Informations de publication
Date de publication:
04 2020
04 2020
Historique:
received:
03
09
2019
revised:
04
11
2019
accepted:
11
11
2019
pubmed:
29
2
2020
medline:
12
9
2020
entrez:
29
2
2020
Statut:
ppublish
Résumé
Perfluoroalkyl (PFAS) substances are widespread in the environment and in organisms. The fact that exposure to PFAS is associated with elevated cholesterol levels is a major concern for human health. Previous investigations, in which bovine serum albumin was frequently studied, indicate that PFOS, PFOA and PFNA bind to serum albumin. However, it is critical to know whether these and other PFAS have a preference for the protein or the lipid fraction in native human blood fractions. For this reason, blood samples from four young healthy volunteers (two women, two men, 23-31 years old) were used for protein size separation and fractionation by the Cohn method in combination with serial ultracentrifugation. The plasma fractions were analyzed for 11 PFAS using high-performance tandem mass spectrometry (HPLC-MS/MS). Although the data are based on a small sample, they clearly show that albumin is the most important carrier protein for PFOS, PFOA, PFHxS, PFNA and PFDA in native human plasma. These five compounds have very little or no affinity for lipoproteins. The confirmation of their transport through albumin is important for the epidemiology of PFAS. The present results must be verified by the examination of a larger number of persons.
Identifiants
pubmed: 32109724
pii: S0160-4120(19)33196-4
doi: 10.1016/j.envint.2019.105324
pii:
doi:
Substances chimiques
Albumins
0
Alkanesulfonic Acids
0
Environmental Pollutants
0
Fluorocarbons
0
Lipids
0
Lipoproteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
105324Informations de copyright
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.